COLOSPA RETARD
Modified-release capsule, hard, 200mg
RxActive license
Active substance (INN)
mebeverine
Pharmaceutical form
Pharmaceutical formModified-release capsule, hard
Strength200mg
PackagingUkupno 30 kapsula sa modifikovanim oslobađanjem tvrdih u blisteru (2x15) u kartonskoj kutiji
ManufacturerMylan Laboratories SAS, France
Therapeutic groupAlimentary tract and metabolism (A03AA04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJuly 23, 2025
Source: CInMED register